Exercise Versus Pharmacological Interventions for Reducing Visceral Adiposity and Improving Health Outcomes

Obesity is considered to be a pandemic that has increased exponentially during the last decades, and yet it still remains largely underdiagnosed and undertreated.1 Findings from large cohort studies suggest that by 2025, global obesity prevalence will reach 18% in men and surpass 21% in women.2 Currently, worldwide overweight and obesity prevalence may be as high as 36.9% and 38.0% in men and women, respectively,3 being even higher in developed countries.3 Obesity predisposes to diverse disorders, including insulin resistance, metabolic syndrome, cardiovascular disease (CVD), and type 2 diabetes (T2D).
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Tags: Editorial Source Type: research